Cardiovascular Catheters Market Report 2026

Cardiovascular Catheters Market Overview

• Cardiovascular Catheters market size has reached to $21.87 billion in 2025 • Expected to grow to $33.24 billion in 2030 at a compound annual growth rate (CAGR) of 8.7% • Growth Driver: Increasing Prevalence of Vascular Heart Diseases Fuels Growth in the Cardiovascular Catheters Market • Market Trend: Innovative Technologies Like TRUEref Drive Precision in Cardiac Mapping • Asia-Pacific was the largest region in 2025 and North America is the fastest growing region.

What Is Covered Under Cardiovascular Catheters Market?

Cardiovascular catheters are flexible, thin tubes inserted into blood vessels to perform diagnostic or therapeutic procedures within the heart and vascular system. They are essential in delivering treatments, monitoring blood flow, and assessing heart conditions. These catheters are a key tool in minimally invasive procedures, allowing physicians to access the heart and blood vessels without open surgery. The main types of products in the cardiovascular catheters market are cardiovascular therapeutic catheters and cardiovascular diagnostic catheters. Cardiovascular therapeutic catheters are specialized devices used in minimally invasive procedures to treat heart and blood vessel conditions, such as opening blocked arteries or correcting abnormal heart rhythms. The various applications include coronary artery diseases (CAD), cardiac arrhythmia, heart failure, and others, and several end users including hospitals, clinics, and ambulatory surgical centers.

What Is The Cardiovascular Catheters Market Growth Forecast?

The cardiovascular catheters market size is expected to see strong growth in the next few years. It will grow to $33.24 billion in 2030 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to development of advanced therapeutic and diagnostic catheters, rising demand for outpatient and ambulatory surgical interventions, integration with imaging and digital monitoring systems, increasing cardiovascular procedure volumes, adoption of biocompatible and smart catheter materials. Major trends in the forecast period include rising adoption of minimally invasive procedures, growth in coronary artery disease interventions, increasing use of electrophysiology and ablation catheters, expansion of stent delivery and angioplasty balloon applications, focus on catheter material innovation and biocompatibility.

Global Cardiovascular Catheters Market Segmentation

1) By Product: Cardiovascular Therapeutic Catheters, Cardiovascular Diagnostic Catheters 2) By Application: Coronary Artery Diseases (CAD), Cardiac Arrhythmia, Heart Failure, Other Applications 3) By End User: Hospitals, Clinics, Ambulatory Surgical Centers Subsegments: 1) By Cardiovascular Therapeutic Catheters: Angioplasty Balloons, Stent Delivery Catheters, Catheters for Ablation Therapy, Intracardiac Catheters, Thrombectomy Catheters 2) By Cardiovascular Diagnostic Catheters: Coronary Angiography Catheters, Pressure Monitoring Catheters, Electrophysiology Catheters, Intravenous Catheters for Diagnostic Imaging

What Is The Driver Of The Cardiovascular Catheters Market?

The increasing prevalence of vascular heart diseases is expected to propel the growth of the cardiovascular catheter market going forward. Vascular heart diseases encompass a group of conditions affecting the blood vessels supplying the heart or within the heart itself. Changes in lifestyle habits such as diet and physical activity, an aging population, and the rising incidence of conditions such as diabetes and hypertension cause vascular heart diseases. Cardiovascular catheters help patients with vascular heart diseases by enabling minimally invasive procedures to diagnose, treat, and manage conditions such as blocked arteries and abnormal heart rhythms, leading to quicker recovery and improved outcomes. For instance, in January 2024, according to the American Heart Association, a US-based nonprofit organization, the number of deaths caused by cardiovascular diseases reached 931,578, compared to 928,741 in 2023. Moreover, the age-adjusted death rate from cardiovascular disease also saw a modest uptick, reaching 233.3 per 100,000, marking a 4.0% increase from the previous year's rate of 224.4 per 100,000. Therefore, the increasing prevalence of vascular heart diseases is driving the cardiovascular catheters industry.

Key Players In The Global Cardiovascular Catheters Market

Major companies operating in the cardiovascular catheters market are Abbott Laboratories, Medtronic plc, Johnson & Johnson MedTech, Koninklijke Philips N.V., Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, Edwards Lifesciences Corporation, W. L. Gore & Associates Inc., ZOLL Medical Corporation, Nipro Corporation, Cook Group Incorporated, Biotronik SE & Co. KG, Merit Medical Systems Inc., LivaNova plc, Cordis Corporation, Asahi Intecc Co. Ltd., AngioDynamics Inc., Endologix Inc., Wellinq, Cardionovum GmbH, Avinger Inc., CathRx, Andocor NV

Global Cardiovascular Catheters Market Trends and Insights

Major companies operating in the cardiovascular catheters market are developing innovative products with advanced technologies, such as TRUEref technology, to enhance the accuracy and reliability of cardiac mapping. TRUEref technology enhances cardiovascular catheters by providing accurate reference signals during cardiac mapping, improving the precision of arrhythmia identification, and enabling more effective and targeted treatments. For instance, in July 2023, Biosense Webster Inc., a US-based company and a part of Johnson & Johnson MedTech, launched OPTRELL mapping catheter, a high-density diagnostic catheter with TRUEref technology. The OPTRELL mapping catheter with TRUEref technology, powered by the CARTO 3 System, offers high-definition electrophysiological mapping with 48 small electrodes, enabling clinicians to map complex cardiac arrhythmias with enhanced precision and develop more effective ablation strategies.

What Are Latest Mergers And Acquisitions In The Cardiovascular Catheters Market?

In April 2023, Abbott, a US-based medical device company, acquired Cardiovascular Systems Inc. for $890 million. The acquisition aims to enhance Abbott's vascular device portfolio with Cardiovascular Systems' innovative atherectomy system, thereby improving peripheral and coronary artery disease treatment options. This acquisition will allow Abbott to provide more comprehensive care for patients with complex arterial conditions. Cardiovascular Systems Inc. is a US-based medical equipment manufacturing company specializing in developing and commercializing catheters and other devices to treat peripheral and coronary artery diseases.

Regional Outlook

Asia-Pacific was the largest region in the cardiovascular catheters market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Cardiovascular Catheters Market?

The cardiovascular catheters market consists of sales of balloon catheters and electrophysiology catheters. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.